An evolving world deserves innovative diagnostics. As the leader in syndromic testing, bioMérieux has evolved our point-of-care diagnostic solutions with a new, PCR-based, CLIA-waived solution with clinicians and their patients in mind. bioMérieux is pleased to announce the SPOTFIRE System and the expanded syndromic BIOFIRE® SPOTFIRE® Respiratory (R) Panel.